Thomas Walther

Showing 1-18 of 18 articles

Interventions for valvular disease

Transcatheter aortic valve implantation with the ACURATE neo valve: indications, procedural aspects and clinical outcomes

Kim W, Hengstenberg C, Hilker M, Schäfer U, Rudolph T, Toggweiler S, Rück A, Søndergaard L, Conradi L, Hamm C, Walther T, Möllmann H, Doss M, Holzamer A, Husser O, Belon C, Delaloye S

April 3, 2020 | 10.4244/EIJ-D-19-00908

Annular versus supra-annular sizing for TAVI in bicuspid aortic valve stenosis

Kim W, Hamm C, Nef H, Walther T, Möllmann H, Doss M, Wiedemeyer J, Fischer-Rasokat U, Rolf A, Renker M, Liebetrau C

June 12, 2019 | 10.4244/EIJ-D-19-00236

Structured minimalist Heart Team – the way forward

Walther T, Walther C

April 5, 2019 | 10.4244/EIJV14I18A314

Interventions for valvular disease

Matched comparison of next- and early-generation balloon-expandable transcatheter heart valve implantations in failed surgical aortic bioprostheses

Seiffert M, Treede H, Schofer J, Linke A, Wöhrle J, Baumbach H, Mehilli J, Bapat V, Simonato M, Walther T, Kullmer M, Boekstegers P, Ensminger S, Kurz T, Eltchaninoff H, Rastan A, Werner N, de Weger A, Frerker C, Lauer B, Mueller O, Whisenant B, Thukkani A, Weisz G, Dvir D

July 20, 2018 | 10.4244/EIJ-D-17-00546

Interventions for valvular disease

Real-world experience using the ACURATE neo prosthesis: 30-day outcomes of 1,000 patients enrolled in the SAVI TF registry

Möllmann H, Hengstenberg C, Hilker M, Kerber S, Schäfer U, Rudolph T, Linke A, Franz N, Kuntze T, Nef H, Kappert U, Walther T, Zembala M, Toggweiler S, Kim W

February 2, 2018 | 10.4244/EIJ-D-17-00628

Interventions for valvular disease

TAVI risk scoring using established versus new scoring systems: role of the new STS/ACC model

Arsalan M, Weferling M, Hecker F, Filardo G, Kim W, Pollock B, Van Linden A, Arsalan-Werner A, Renker M, Doss M, Kalbas S, Hamm C, Liebetrau C, Mack M, Walther T

January 19, 2018 | 10.4244/EIJ-D-17-00421

Transfemoral TAVI using the self-expanding ACURATE neo prosthesis: one-year outcomes of the multicentre “CE-approval cohort”

Möllmann H, Walther T, Siqueira D, Diemert P, Treede H, Grube E, Nickenig G, Baldus S, Rudolph T, Kuratani T, Sawa Y, Kempfert J, Kim W, Abizaid A

October 11, 2017 | 10.4244/EIJ-D-17-00187

Interventions for valvular disease

Left ventricular function determines the survival benefit for women over men after transcatheter aortic valve implantation (TAVI)

Bauer T, Möllmann H, Beckmann A, Ensminger S, Frerker C, Holzhey D, Berkowitsch A, Zahn R, Mohr F, Hamm C, Walther T

July 20, 2017 | 10.4244/EIJ-D-16-00622

Interventions for valvular disease

How should I treat a patient with a symptomatic and severe low-flow low-gradient aortic stenosis and an incidental abdominal aortic aneurysm?

Rahhab Z, Raa S, van der Ploeg N, Van Mieghem N, Verhagen H, de Jaegere P, Arsalan M, Kim W, Walther T, Tchétché D

July 20, 2017 | 10.4244/EIJ-D-16-00461

Interventions for valvular disease

Multicentre clinical study evaluating a novel resheathable annular functioning self-expanding transcatheter aortic valve system: safety and performance results at 30 days with the Portico system

Manoharan G, Linke A, Möllmann H, Redwood S, Frerker C, Kovac J, Walther T

August 20, 2016 | 10.4244/EIJV12I6A125

Interventions for valvular disease

Thirty-day outcomes in patients at intermediate risk for surgery from the SAPIEN 3 European approval trial

Vahanian A, Urena M, Walther T, Treede H, Wendler O, Lefèvre T, Spence M, Redwood S, Kahlert P, Rodés-Cabau J, Leipsic J, Webb J

June 10, 2016 | 10.4244/EIJV12I2A37

TAVI for low-flow, low-gradient severe aortic stenosis with preserved or reduced ejection fraction: a subgroup analysis from the German Aortic Valve Registry (GARY)

Lauten A, Figulla HR, Möllmann H, Holzhey D, Kotting J, Beckmann A, Veit C, Cremer J, Kuck K, Lange R, Zahn R, Sack S, Schuler G, Walther T, Beyersdorf F, Böhm M, Heusch G, Meinertz T, Neumann T, Welz A, Mohr F, Hamm C

November 20, 2014 | 10.4244/EIJV10I7A145

TAVI: transapical - what else?

Walther T, Arsalan M, Kim W, Kempfert J

September 15, 2013 | 10.4244/EIJV9SSA5

Symetis ACURATE TA valve

Kempfert J, Möllmann H, Walther T

September 30, 2012 | 10.4244/EIJV8SQA19

The SURTAVI model: proposal for a pragmatic risk stratification for patients with severe aortic stenosis

Van Mieghem N, Head S, van der Boon R, Piazza N, de Jaegere P, Carrel T, Kappetein A, Lange R, Walther T, Windecker S, Van Es G-A, Serruys P

June 27, 2012 | 10.4244/EIJV8I2A40

What is the evidence allowing us to state that transcatheter aortic valve replacement via the femoral artery is a more attractive option compared to transapical valve replacement?

Kappetein A, Head S, Treede H, Reichenspurner H, Mohr F, Walther T

December 30, 2011 | 10.4244/EIJV7I8A143

Transcatheter aortic valve implantation – should we do it just because we can?

Walther T, Falk V

August 20, 2008

Transcatheter valve implantation for patients with aortic stenosis: a position statement from the European Association of Cardio-Thoracic Surgery (EACTS) and the European Society of Cardiology (ESC), in collaboration with the European Association of Percutaneous Cardiovascular Interventions (EAPCI)

Vahanian A, Alfieri O, Al-Attar N, Antunes M, Bax J, Cormier B, Cribier A, de Jaegere P, Fournial G, Kappetein A, Kovac J, Ludgate S, Maisano F, Moat N, Mohr F, Nataf P, Pierard L, Pomar J-L, Schofer J, Tornos P, Tuzcu ME, van Hout B, von Segesser L, Walther T

August 20, 2008

Latest news

NEW ISSUE

State of the Art on ViV-TAVI; Transseptal Punctures; Endovascular Closure and TF-TAVI; Percutaneous PVL Closure: Long-Term Outcomes; and more

October 20, 2021

STATE OF THE ART

Valve-in-valve TAVI: a practical overview

Giuseppe Tarantini et al.

October 20, 2021

AHEAD OF PRINT

TAVI in younger (<70 years old) patients: the AMTRAC registry

Guy Witberg et al.

October 22, 2021

AHEAD OF PRINT

Impact of LVOT calcification in transfemoral TAVI patients

L. Waldschmidt et al.

Impact of preprocedural biological markers on 10-year mortality in the SYNTAXES trial

Hironori Hara et al.

October 22, 2021

AHEAD OF PRINT

Serum caffeine causes adenosine-induced FFR overestimation

Hideaki Tanaka et al.